查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1428600

生物樣本庫市場：2024-2034

Biobanking Market Report 2024-2034
出版日期: | 出版商: Visiongain | 英文 264 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2034 年，全球生物樣本庫市場規模將以 9.1% 的複合年增長率成長。

生物樣本庫越來越受到世界各國政府、研究機構和金融機構的認可和支持，導致對這些設施的投資激增。特別是，像美國國立衛生研究院 (NIH) 資助的Biorepository and Precision Medicine Initiative Cohort Program這樣的舉措已經從超過 100 萬人身上收集了生物樣本，以建立全面的國家研究資源。歐盟委員會也資助生物樣本庫和生物分子資源研究基礎設施 (BBMRI)，這是一個專注於生物樣本庫和生物分子資源的泛歐洲機構。這種日益增加的關注和財政支持凸顯了生物樣本庫在推動全球科學研究和精準醫療方面的戰略重要性。

本報告調查了全球生物樣本庫市場，並提供了市場概況、影響市場成長和市場機會的因素分析、市場規模趨勢和預測、各個細分市場和地區的詳細分析、競爭格局和主要公司概況等。 。

目錄

第 1 章報告概述

第 2 章執行摘要

第三章市場概況

  • 主要發現
  • 市場動態
    • 市場驅動力
    • 市場制約因素
    • 市場機會
  • COVID-19 影響分析
  • 波特五力分析
  • PEST分析

第四章生物樣本庫市場分析：依所有權類別

  • 主要發現
  • 市場吸引力指數
  • 市場規模趨勢和預測
  • 國家/地方機構
  • 大學
  • 非營利性
  • 私人的
    • 市場規模趨勢與預測：按地區
    • 市佔率：按地區

第五章生物樣本庫市場分析：依樣本

  • 主要發現
  • 市場吸引力指數
  • 市場規模趨勢和預測
  • 血液製品
  • 人體組織
  • 核酸
  • 細胞系
  • 體液
  • 其他
    • 市場規模趨勢與預測：按地區
    • 市佔率：按地區

第六章生物樣本庫市場分析：依應用分類

  • 主要發現
  • 市場吸引力指數
  • 市場規模趨勢和預測
  • 再生醫學
  • 生命科學研究
  • 臨床研究
    • 市場規模趨勢與預測：按地區
    • 市佔率：按地區

第 7 章生物樣本庫市場分析：依產品/服務

  • 主要發現
  • 市場吸引力指數
  • 市場規模趨勢和預測
  • 設備
  • 消耗品
  • 服務
  • 軟件
    • 市場規模趨勢與預測：按地區
    • 市佔率：按地區

第 8 章生物樣本庫市場分析：按最終用戶

  • 主要發現
  • 市場吸引力指數
  • 市場規模趨勢和預測
  • 製藥和生物技術公司
  • 合約研究組織
  • 學術研究所
  • 醫院
    • 市場規模趨勢與預測：按地區
    • 市佔率：按地區

第九章生物樣本庫市場分析：按地區

  • 主要發現
  • 市場規模趨勢和預測

第十章北美生物樣本庫市場分析

第十一章歐洲生物樣本庫市場分析

第十二章亞太生物樣本庫市場分析

第十三章中東與非洲生物樣本庫市場分析

第十四章拉丁美洲生物樣本庫市場分析

第十五章公司簡介

  • Thermo Fisher Scientific, Inc.
  • PHC Holdings Corporation
  • Hamilton Company
  • Avantor Inc.
  • Qiagen N.V.
  • Tecan Trading AG
  • Merck & Co., Inc.
  • Cryoport Inc.
  • Azenta Inc.
  • Isenet Biobanking
  • CTI Biotech
  • Boca Biolistics
  • BIOIVT &ELEVATING SCIENCE
  • US Biolab Corp. Inc.
  • ProteoGenex Inc.
  • ASKION GmbH

第 16 章 一般評論/建議

  • Visiongain 的一般討論
  • 對參賽者的建議
Product Code: PHA1317

The global Biobanking market is projected to grow at a CAGR of 9.1% by 2034

The Biobanking Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Investments and Funding Projected to Boost Industry Growth

Biobanks are experiencing increased acknowledgment and support from global governments, research bodies, and financial institutions, leading to a surge in investment in these facilities. Notably, initiatives like the Biorepository and Precision Medicine Initiative Cohort Program, funded by the U.S. National Institutes of Health (NIH), seek to amass biological samples from over a million individuals to establish a comprehensive national research resource. Concurrently, the European Commission has committed funding to the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI), a pan-European facility focused on biobanking and biomolecular resources. This heightened attention and financial backing underscore the strategic importance of biobanks in advancing scientific research and precision medicine on a global scale.

Hight Cost of Equipment Likely to Challenge Industry Growth

The market's growth potential is anticipated to face limitations due to the substantial expenses associated with automated equipment. While cutting-edge technologies like advanced sample handling systems have the potential to enhance operational efficiency and elevate the quality of biobanking processes, their high price tags pose a considerable challenge, particularly for smaller biobanking enterprises or those with constrained financial capacities. Take, for instance, the expenditure involved in acquiring an automated storage system, which can vary based on its size and complexity. The initial capital outlay for such systems can be substantial, ranging from tens of thousands to hundreds of thousands of dollars. Beyond the initial investment, ongoing considerations encompass maintenance and operational expenses, including software updates, repairs, and training. This cost factor serves as a strategic consideration for businesses evaluating the incorporation of automated equipment in their biobanking operations.

What Questions Should You Ask before Buying a Market Research Report?

How is the biobanking market evolving?

What is driving and restraining the biobanking market?

How will each biobanking submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each biobanking submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading biobanking markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the biobanking projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of

biobanking projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the biobanking market?

Where is the biobanking market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the biobanking market today, and over the next 10 years:

Our 264-page report provides 121 tables and 182 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the biobanking market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Ownership

National/Regional Agencies

Universities

Non-profit

Private

Product and Service

Equipment

Consumables

Services

Software

Sample

Blood Products

Human Tissues

Nucleic Acids

Cell Lines

Biological Fluids

Others

Application

Regenerative Medicine

Life Science Research

Clinical Research

End-users

Pharmaceutical & Biotechnology Companies

CROs

Academic & Research Institutes

Hospitals

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

Japan

China

India

Australia

South Korea

South-East Asia

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Biobanking Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

ASKION GmbH

Avantor Inc.

Azenta Inc.

Boca Biolistics

BIOIVT & ELEVATING SCIENCE

Cryoport Inc.

CTI Biotech

Hamilton Company

Isenet Biobanking

Merck & Co., Inc.

PHC Holdings Corporation

ProteoGenex Inc.

Qiagen N.V.

Thermo Fisher Scientific, Inc.

Tecan Trading AG

US Biolab Corp. Inc.

Overall world revenue for Biobanking Market, 2024 to 2034 in terms of value the market will surpass US$75.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Biobanking Market, 2024 to 2034 report help you?

In summary, our 260+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Biobanking Market 2024 to 2034, with forecasts for ownership, product and service, sample, application, end-users each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 22 key national markets - See forecasts for the Biobanking Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 16 of the major companies involved in the Biobanking Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Biobanking Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Biobanking Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Increased Focus on Precision Medicine and Genetic Testing
      • 3.2.1.2 Growing Demand for Umbilical Cord Blood Banking
      • 3.2.1.3 Evolution of Biobanks Rapidly Enabling Massive Collections of Biological Materials and Associated Information
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Private Sponsorship Has Raised a Number of Ethical Issues
      • 3.2.2.2 Issues Related to Biospecimen Sample Procurement
      • 3.2.2.3 Long-term Sustainability of Biobanks
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Human Biospecimens are Essential for Progress in Biomarker Discovery and Customised Treatment
      • 3.2.3.2 Opportunities for Cardiovascular Research
      • 3.2.3.3 Growing Focus on the R&D of Cell Therapies
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat of Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Biobanking Market Analysis by Ownership

  • 4.1 Key Findings
  • 4.2 Ownership Segment: Market Attractiveness Index
  • 4.3 Biobanking Market Size Estimation and Forecast by Ownership
  • 4.4 National/Regional Agencies
    • 4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Universities
    • 4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 Non-profit
    • 4.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 Private
    • 4.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)

5 Biobanking Market Analysis by Sample

  • 5.1 Key Findings
  • 5.2 Sample Segment: Market Attractiveness Index
  • 5.3 Biobanking Market Size Estimation and Forecast by Sample
  • 5.4 Blood Products
    • 5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Human Tissues
    • 5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Nucleic Acids
    • 5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 5.7 Cell Lines
    • 5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.7.2 Market Share by Region, 2024 & 2034 (%)
  • 5.8 Biological Fluids
    • 5.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.8.2 Market Share by Region, 2024 & 2034 (%)
  • 5.9 Others
    • 5.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.9.2 Market Share by Region, 2024 & 2034 (%)

6 Biobanking Market Analysis by Application

  • 6.1 Key Findings
  • 6.2 Application Segment: Market Attractiveness Index
  • 6.3 Biobanking Market Size Estimation and Forecast by Application
  • 6.4 Regenerative Medicine
    • 6.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Life Science Research
    • 6.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)
  • 6.6 Clinical Research
    • 6.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 6.6.2 Market Share by Region, 2024 & 2034 (%)

7 Biobanking Market Analysis by Product and Service

  • 7.1 Key Findings
  • 7.2 Product and Service Segment: Market Attractiveness Index
  • 7.3 Biobanking Market Size Estimation and Forecast by Product and Service
  • 7.4 Equipment
    • 7.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 7.4.2 Market Share by Region, 2024 & 2034 (%)
  • 7.5 Consumables
    • 7.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 7.5.2 Market Share by Region, 2024 & 2034 (%)
  • 7.6 Services
    • 7.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 7.6.2 Market Share by Region, 2024 & 2034 (%)
  • 7.7 Software
    • 7.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 7.7.2 Market Share by Region, 2024 & 2034 (%)

8 Biobanking Market Analysis by End-users

  • 8.1 Key Findings
  • 8.2 End-users Segment: Market Attractiveness Index
  • 8.3 Biobanking Market Size Estimation and Forecast by End-users
  • 8.4 Pharmaceutical & Biotechnology Companies
    • 8.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 8.4.2 Market Share by Region, 2024 & 2034 (%)
  • 8.5 CROs
    • 8.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 8.5.2 Market Share by Region, 2024 & 2034 (%)
  • 8.6 Academic & Research Institutes
    • 8.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 8.6.2 Market Share by Region, 2024 & 2034 (%)
  • 8.7 Hospitals
    • 8.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 8.7.2 Market Share by Region, 2024 & 2034 (%)

9 Biobanking Market Analysis by Region

  • 9.1 Key Findings
  • 9.2 Regional Market Size Estimation and Forecast

10 North America Biobanking Market Analysis

  • 10.1 Key Findings
  • 10.2 North America Biobanking Market Attractiveness Index
  • 10.3 North America Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 10.4 North America Biobanking Market Size Estimation and Forecast by Country
  • 10.5 North America Biobanking Market Size Estimation and Forecast by Ownership
  • 10.6 North America Biobanking Market Size Estimation and Forecast by Sample
  • 10.7 North America Biobanking Market Size Estimation and Forecast by Application
  • 10.8 North America Biobanking Market Size Estimation and Forecast by Product and Service
  • 10.9 North America Biobanking Market Size Estimation and Forecast by End-users
  • 10.10 U.S. Biobanking Market Analysis
  • 10.11 Canada Biobanking Market Analysis

11 Europe Biobanking Market Analysis

  • 11.1 Key Findings
  • 11.2 Europe Biobanking Market Attractiveness Index
  • 11.3 Europe Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 11.4 Europe Biobanking Market Size Estimation and Forecast by Country
  • 11.5 Europe Biobanking Market Size Estimation and Forecast by Ownership
  • 11.6 Europe Biobanking Market Size Estimation and Forecast by Sample
  • 11.7 Europe Biobanking Market Size Estimation and Forecast by Application
  • 11.8 Europe Biobanking Market Size Estimation and Forecast by Product and Service
  • 11.9 Europe Biobanking Market Size Estimation and Forecast by End-users
  • 11.10 Germany Biobanking Market Analysis
  • 11.11 UK Biobanking Market Analysis
  • 11.12 France Biobanking Market Analysis
  • 11.13 Italy Biobanking Market Analysis
  • 11.14 Spain Biobanking Market Analysis
  • 11.15 Russia Biobanking Market Analysis
  • 11.16 Rest of Europe Biobanking Market Analysis

12 Asia Pacific Biobanking Market Analysis

  • 12.1 Key Findings
  • 12.2 Asia Pacific Biobanking Market Attractiveness Index
  • 12.3 Asia Pacific Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 12.4 Asia Pacific Biobanking Market Size Estimation and Forecast by Country
  • 12.5 Asia Pacific Biobanking Market Size Estimation and Forecast by Ownership
  • 12.6 Asia Pacific Biobanking Market Size Estimation and Forecast by Sample
  • 12.7 Asia Pacific Biobanking Market Size Estimation and Forecast by Application
  • 12.8 Asia Pacific Biobanking Market Size Estimation and Forecast by Product and Service
  • 12.9 Asia Pacific Biobanking Market Size Estimation and Forecast by End-users
  • 12.10 Japan Biobanking Market Analysis
  • 12.11 China Biobanking Market Analysis
  • 12.12 India Biobanking Market Analysis
  • 12.13 Australia Biobanking Market Analysis
  • 12.14 South Korea Biobanking Market Analysis
  • 12.15 South-East Asia Biobanking Market Analysis
  • 12.16 Rest of Asia Pacific Biobanking Market Analysis

13 Latin America Biobanking Market Analysis

  • 13.1 Key Findings
  • 13.2 Latin America Biobanking Market Attractiveness Index
  • 13.3 Latin America Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 13.4 Latin America Biobanking Market Size Estimation and Forecast by Country
  • 13.5 Latin America Biobanking Market Size Estimation and Forecast by Ownership
  • 13.6 Latin America Biobanking Market Size Estimation and Forecast by Sample
  • 13.7 Latin America Biobanking Market Size Estimation and Forecast by Application
  • 13.8 Latin America Biobanking Market Size Estimation and Forecast by Product and Service
  • 13.9 Latin America Biobanking Market Size Estimation and Forecast by End-users
  • 13.10 Brazil Biobanking Market Analysis
  • 13.11 Mexico Biobanking Market Analysis
  • 13.12 Rest of Latin America Biobanking Market Analysis

14 MEA Biobanking Market Analysis

  • 14.1 Key Findings
  • 14.2 MEA Biobanking Market Attractiveness Index
  • 14.3 MEA Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 14.4 MEA Biobanking Market Size Estimation and Forecast by Country
  • 14.5 MEA Biobanking Market Size Estimation and Forecast by Ownership
  • 14.6 MEA Biobanking Market Size Estimation and Forecast by Sample
  • 14.7 MEA Biobanking Market Size Estimation and Forecast by Application
  • 14.8 MEA Biobanking Market Size Estimation and Forecast by Product and Service
  • 14.9 MEA Biobanking Market Size Estimation and Forecast by End-users
  • 14.10 GCC Biobanking Market Analysis
  • 14.11 South Africa Biobanking Market Analysis
  • 14.12 Rest of MEA Biobanking Market Analysis

15 Company Profiles

  • 15.1 Thermo Fisher Scientific, Inc.
    • 15.1.1 Company Snapshot
    • 15.1.2 Company Overview
    • 15.1.3 Financial Analysis
      • 15.1.3.1 Net Revenue, 2015-2022
      • 15.1.3.2 Regional Market Shares, 2022
      • 15.1.3.3 R&D, 2015-2022
    • 15.1.4 Product Benchmarking
  • 15.2 PHC Holdings Corporation
    • 15.2.1 Company Snapshot
    • 15.2.2 Company Overview
    • 15.2.3 Product Benchmarking
    • 15.2.4 Strategic Outlook
  • 15.3 Hamilton Company
    • 15.3.1 Company Snapshot
    • 15.3.2 Company Overview
    • 15.3.3 Product Benchmarking
  • 15.4 Avantor Inc.
    • 15.4.1 Company Snapshot
    • 15.4.2 Company Overview
    • 15.4.3 Financial Analysis
      • 15.4.3.1 Net Revenue, 2015-2022
      • 15.4.3.2 Regional Market Shares, 2022
    • 15.4.4 Product Benchmarking
  • 15.5 Qiagen N.V.
    • 15.5.1 Company Snapshot
    • 15.5.2 Company Overview
    • 15.5.3 Financial Analysis
      • 15.5.3.1 Net Revenue, 2015-2022
      • 15.5.3.2 Regional Market Shares, 2022
      • 15.5.3.3 R&D, 2015-2022
    • 15.5.4 Product Benchmarking
  • 15.6 Tecan Trading AG
    • 15.6.1 Company Snapshot
    • 15.6.2 Company Overview
    • 15.6.3 Product Benchmarking
  • 15.7 Merck & Co., Inc.
    • 15.7.1 Company Snapshot
    • 15.7.2 Company Overview
    • 15.7.3 Financial Analysis
      • 15.7.3.1 Net Revenue, 2015-2022
      • 15.7.3.2 Regional Market Shares, 2022
      • 15.7.3.3 R&D, 2015-2022
    • 15.7.4 Product Benchmarking
  • 15.8 Cryoport Inc.
    • 15.8.1 Company Snapshot
    • 15.8.2 Company Overview
    • 15.8.3 Financial Analysis
      • 15.8.3.1 Net Revenue, 2015-2022
      • 15.8.3.2 Regional Market Shares, 2022
      • 15.8.3.3 R&D, 2015-2022
    • 15.8.4 Product Benchmarking
    • 15.8.5 Strategic Outlook
  • 15.9 Azenta Inc.
    • 15.9.1 Company Snapshot
    • 15.9.2 Company Overview
    • 15.9.3 Financial Analysis
      • 15.9.3.1 Net Revenue, 2015-2022
      • 15.9.3.2 R&D, 2015-2022
    • 15.9.4 Product Benchmarking
  • 15.10 Isenet Biobanking
    • 15.10.1 Company Snapshot
    • 15.10.2 Company Overview
    • 15.10.3 Product Benchmarking
  • 15.11 CTI Biotech
    • 15.11.1 Company Snapshot
    • 15.11.2 Company Overview
    • 15.11.3 Product Benchmarking
  • 15.12 Boca Biolistics
    • 15.12.1 Company Snapshot
    • 15.12.2 Company Overview
    • 15.12.3 Product Benchmarking
    • 15.12.4 Strategic Outlook
  • 15.13 BIOIVT & ELEVATING SCIENCE
    • 15.13.1 Company Snapshot
    • 15.13.2 Company Overview
    • 15.13.3 Product Benchmarking
    • 15.13.4 Strategic Outlook
  • 15.14 US Biolab Corp. Inc.
    • 15.14.1 Company Snapshot
    • 15.14.2 Company Overview
    • 15.14.3 Product Benchmarking
  • 15.15 ProteoGenex Inc.
    • 15.15.1 Company Snapshot
    • 15.15.2 Company Overview
    • 15.15.3 Product Benchmarking
  • 15.16 ASKION GmbH
    • 15.16.1 Company Snapshot
    • 15.16.2 Company Overview
    • 15.16.3 Product Benchmarking

16 Conclusion and Recommendations

  • 16.1 Concluding Remarks from Visiongain
  • 16.2 Recommendations for Market Players

List of Tables

  • Table 1 Biobanking Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
  • Table 2 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 7 National/Regional Agencies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 8 Universities Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 9 Non-profit Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 10 Private Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 11 Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 12 Blood Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 13 Human Tissues Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 14 Nucleic Acid Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 15 Cell Lines Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 16 Biological Fluids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 17 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 18 Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 19 Regenerative Medicine Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 20 Life Science Research Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 21 Clinical Research Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 22 Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 23 Equipment Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 24 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 25 Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 26 Software Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 27 Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 28 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 29 CROs Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 30 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 31 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 32 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 33 North America Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 34 North America Biobanking Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 35 North America Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 36 North America Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 37 North America Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 38 North America Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 39 U.S. Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 40 Canada Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 41 Europe Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 42 Europe Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 43 Europe Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 44 Europe Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 45 Europe Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 46 Europe Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 47 Germany Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 48 UK Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 49 France Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 50 Italy Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 51 Spain Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 52 Russia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 53 Rest of Europe Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 54 Asia Pacific Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 55 Asia Pacific Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 56 Asia Pacific Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 57 Asia Pacific Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 58 Asia Pacific Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 59 Asia Pacific Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 60 Japan Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 61 China Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 62 India Biobanking Institutes
  • Table 63 India Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 64 Australia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 65 South Korea Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 66 South-East Asia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 67 Rest of Asia Pacific Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 68 Latin America Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 69 Latin America Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 70 Latin America Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 71 Latin America Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 72 Latin America Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 73 Latin America Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 74 Brazil Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 75 Mexico Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 76 Rest of Latin America Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 77 MEA Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 78 MEA Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 79 MEA Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 80 MEA Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 81 MEA Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 82 MEA Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 83 GCC Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 84 South Africa Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 85 Rest of MEA Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 86 Thermo Fisher Scientific, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 87 Thermo Fisher Scientific, Inc.: Product Benchmarking
  • Table 88 PHC Holdings Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 89 PHC Holdings Corporation: Product Benchmarking
  • Table 90 PHC Holdings Corporation: Strategic Outlook
  • Table 91 Hamilton Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 92 Hamilton Company: Product Benchmarking
  • Table 93 Avantor Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 94 Avantor Inc.: Product Benchmarking
  • Table 95 Qiagen N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 96 Qiagen N.V.: Product Benchmarking
  • Table 97 Tecan Trading AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 Tecan Trading AG: Product Benchmarking
  • Table 99 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 100 Merck & Co., Inc.: Product Benchmarking
  • Table 101 Cryoport Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Cryoport Inc.: Product Benchmarking
  • Table 103 Cryoport Inc.: Strategic Outlook
  • Table 104 Azenta Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 105 Azenta Inc.: Product Benchmarking
  • Table 106 Isenet Biobanking: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Isenet Biobanking: Product Benchmarking
  • Table 108 CTI Biotech: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 CTI Biotech: Product Benchmarking
  • Table 110 Boca Biolistics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 Boca Biolistics: Product Benchmarking
  • Table 112 Boca Biolistics: Strategic Outlook
  • Table 113 BIOIVT & ELEVATING SCIENCE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 114 BIOIVT & ELEVATING SCIENCE: Product Benchmarking
  • Table 115 BIOIVT & ELEVATING SCIENCE: Strategic Outlook
  • Table 116 US Biolab Corp. Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 117 US Biolab Corp. Inc.: Product Benchmarking
  • Table 118 ProteoGenex Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 119 ProteoGenex Inc.: Product Benchmarking
  • Table 120 ASKION GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 121 ASKION GmbH: Product Benchmarking
  •  

List of Figures

  • Figure 1 Biobanking Market Segmentation
  • Figure 2 Biobanking Market by Ownership: Market Attractiveness Index
  • Figure 3 Biobanking Market by Sample: Market Attractiveness Index
  • Figure 4 Biobanking Market by Application: Market Attractiveness Index
  • Figure 5 Biobanking Market by Product and Service: Market Attractiveness Index
  • Figure 6 Biobanking Market by End-users: Market Attractiveness Index
  • Figure 7 Biobanking Market Attractiveness Index by Region
  • Figure 8 Biobanking Market: Market Dynamics
  • Figure 9 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %): "V" Shaped Recovery
  • Figure 10 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %): "U" Shaped Recovery
  • Figure 11 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %): "W" Shaped Recovery
  • Figure 12 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %): "L" Shaped Recovery
  • Figure 13 Biobanking Market: Porter's Five Forces Analysis
  • Figure 14 Biobanking Market: PEST Analysis
  • Figure 15 Biobanking Market Attractiveness Index by Ownership
  • Figure 16 Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)
  • Figure 17 Biobanking Market Share Forecast by Ownership, 2024, 2029, 2034 (%)
  • Figure 18 National/Regional Agencies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 19 National/Regional Agencies Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 20 Universities Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 21 Universities Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 22 Non-profit Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 23 Non-profit Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 24 Private Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 25 Private Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 26 Biobanking Market Attractiveness Index by Ownership
  • Figure 27 Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)
  • Figure 28 Biobanking Market Share Forecast by Sample, 2024, 2029, 2034 (%)
  • Figure 29 Blood Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 30 Blood Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 31 Human Tissues Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 32 Human Tissues Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 33 Nucleic Acids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 34 Nucleic Acids Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 35 Cell Lines Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 36 Cell Lines Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 37 Biological Fluids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 38 Biological Fluids Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 39 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 40 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 41 Biobanking Market Attractiveness Index by Application
  • Figure 42 Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 43 Biobanking Market Share Forecast by Application, 2024, 2029, 2034 (%)
  • Figure 44 Regenerative Medicine Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 45 Regenerative Medicine Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 46 Life Science Research Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 47 Life Science Research Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 48 Clinical Research Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 49 Clinical Research Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 50 Biobanking Market Attractiveness Index by Product and Service
  • Figure 51 Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)
  • Figure 52 Biobanking Market Share Forecast by Product and Service, 2024, 2029, 2034 (%)
  • Figure 53 Equipment Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 54 Equipment Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 55 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 56 Consumables Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 57 Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 58 Services Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 59 Software Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 60 Software Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 61 Biobanking Market Attractiveness Index by End-users
  • Figure 62 Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 63 Biobanking Market Share Forecast by End-users, 2024, 2029, 2034 (%)
  • Figure 64 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 65 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 66 CROs Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 67 CROs Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 68 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 69 Academic & Research Institutes Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 70 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 71 Hospitals Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 72 Biobanking Market Forecast by Region 2024, 2029, 2034 (Revenue, CAGR%)
  • Figure 73 Biobanking Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 74 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 75 North America Biobanking Market Attractiveness Index
  • Figure 76 North America Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 77 North America Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)
  • Figure 78 North America Biobanking Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 79 North America Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)
  • Figure 80 North America Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)
  • Figure 81 North America Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)
  • Figure 82 North America Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)
  • Figure 83 North America Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 84 North America Biobanking Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 85 North America Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)
  • Figure 86 North America Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)
  • Figure 87 North America Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 88 North America Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 89 U.S. Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 90 Canada Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 91 Europe Biobanking Market Attractiveness Index
  • Figure 92 Europe Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 93 Europe Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)
  • Figure 94 Europe Biobanking Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 95 Europe Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)
  • Figure 96 Europe Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)
  • Figure 97 Europe Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)
  • Figure 98 Europe Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)
  • Figure 99 Europe Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 100 Europe Biobanking Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 101 Europe Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)
  • Figure 102 Europe Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)
  • Figure 103 Europe Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 104 Europe Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 105 Germany Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 106 UK Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 107 France Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 108 Italy Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 109 Spain Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 110 Russia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 111 Rest of Europe Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 112 Asia Pacific Biobanking Market Attractiveness Index
  • Figure 113 Asia Pacific Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 114 Asia Pacific Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)
  • Figure 115 Asia Pacific Biobanking Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 116 Asia Pacific Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)
  • Figure 117 Asia Pacific Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)
  • Figure 118 Asia Pacific Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)
  • Figure 119 Asia Pacific Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)
  • Figure 120 Asia Pacific Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 121 Asia Pacific Biobanking Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 122 Asia Pacific Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)
  • Figure 123 Asia Pacific Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)
  • Figure 124 Asia Pacific Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 125 Asia Pacific Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 126 Japan Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 127 China Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 128 India Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 129 Australia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 130 South Korea Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 131 South-East Asia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 132 Rest of Asia Pacific Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 133 Latin America Biobanking Market Attractiveness Index
  • Figure 134 Latin America Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 135 Latin America Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)
  • Figure 136 Latin America Biobanking Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 137 Latin America Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)
  • Figure 138 Latin America Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)
  • Figure 139 Latin America Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)
  • Figure 140 Latin America Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)
  • Figure 141 Latin America Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 142 Latin America Biobanking Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 143 Latin America Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)
  • Figure 144 Latin America Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)
  • Figure 145 Latin America Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 146 Latin America Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 147 Brazil Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 148 Mexico Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 149 Rest of Latin America Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 150 MEA Biobanking Market Attractiveness Index
  • Figure 151 MEA Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 152 MEA Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)
  • Figure 153 MEA Biobanking Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 154 MEA Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)
  • Figure 155 MEA Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)
  • Figure 156 MEA Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)
  • Figure 157 MEA Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)
  • Figure 158 MEA Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 159 MEA Biobanking Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 160 MEA Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)
  • Figure 161 MEA Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)
  • Figure 162 MEA Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 163 MEA Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 164 GCC Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 165 South Africa Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 166 Rest of MEA Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 167 Thermo Fisher Scientific, Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)
  • Figure 168 Thermo Fisher Scientific, Inc.: Regional Market Shares (%), 2022
  • Figure 169 Thermo Fisher Scientific, Inc.: R&D, 2015-2022 (US$ Million, AGR%)
  • Figure 170 Avantor Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)
  • Figure 171 Avantor Inc.: Regional Market Shares (%), 2022
  • Figure 172 Qiagen N.V.: Net Revenue, 2015-2022 (US$ Million, AGR%)
  • Figure 173 Qiagen N.V.: Regional Market Shares (%), 2022
  • Figure 174 Qiagen N.V.: R&D, 2015-2022 (US$ Million, AGR%)
  • Figure 175 Merck & Co., Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)
  • Figure 176 Merck & Co., Inc.: Regional Market Shares (%), 2022
  • Figure 177 Merck & Co., Inc.: R&D, 2015-2022 (US$ Million, AGR%)
  • Figure 178 Cryoport Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)
  • Figure 179 Cryoport Inc.: Regional Market Shares (%), 2022
  • Figure 180 Cryoport Inc.: R&D, 2015-2022 (US$ Million, AGR%)
  • Figure 181 Azenta Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)
  • Figure 182 Azenta Inc.: R&D, 2015-2022 (US$ Million, AGR%)